Related Experiment Video

Updated: Jun 4, 2025

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

744

RF - OX40: A Promising Therapeutic Target in Moderate-to-Severe Atopic Dermatitis

M Zulaika-Lloret1, M Rodriguez-Troncoso1, R Ruiz-Villaverde1

  • 1Servicio de Dermatología, Hospital Universitario San Cecilio; Instituto Biosanitario de Granada (ibs.GRANADA), Granada, España.

Actas Dermo-Sifiliograficas
|January 2, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Atopic dermatitisBiological treatmentDermatitis atópicaOX40Tratamiento biológico

More Related Videos

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.1K
Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

1.8K

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
241